Sponsored By
thumbnail
Cardiovascular
Bivacor Keeps Total Artificial Heart Market Pumping with IDEBivacor Keeps TAH Market Pumping with IDE
The Houston, TX-based company said it will begin a first-in-human study of the Bivacor Total Artificial Heart.
Sign up for the QMED & MD+DI Daily newsletter.